Relations (1)

related 3.91 — strongly supporting 6 facts

Chemotherapy is a primary treatment modality for breast cancer, as evidenced by its use in clinical studies and patient care [1], [2], and [3]. Research frequently examines the long-term physical and psychological impacts of this treatment on breast cancer patients [4], [5], [6], and [7].

Facts (6)

Sources
Extent and Health Consequences of Chronic Sleep Loss and ... - NCBI ncbi.nlm.nih.gov Colten HR, Altevogt BM · National Academies Press 2 facts
referenceBerger and Higginbotham (2000) conducted a pilot study on the correlates of fatigue in patients during and following adjuvant breast cancer chemotherapy.
referenceBroeckel JA, Jacobsen PB, Horton J, Balducci L, and Lyman GH published a study titled 'Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer' in the Journal of Clinical Oncology in 1998 (Volume 16, Issue 5, pages 1689–1696).
Crucial Answers on Long-Term Physical Health Effects From Breast ... cancernetwork.com CancerNetwork 2 facts
claimClara Bodelon, PhD, MS, a senior principal scientist of survivor research at the American Cancer Society, published a study in JAMA Network Open indicating that chemotherapy leads to more significant long-term physical health declines in breast cancer patients compared to endocrine therapy.
claimWomen who received chemotherapy for breast cancer experience long-term declines in physical health compared to cancer-free women of the same age, with these effects persisting beyond 5 years post-diagnosis.
Long-term and Late Effects of Cancer cancer.org American Cancer Society 1 fact
claimCertain cancer treatments increase the risk for a second (secondary) cancer, such as acute myelogenous leukemia after chemotherapy or breast cancer after radiation to the chest.
Medicinal plants: bioactive compounds, biological activities ... frontiersin.org Frontiers in Immunology 1 fact
claimNatural alkaloids from Dicranostigma leptopodum (Maxim.) fedde and their G5. NHAc-PBA dendrimer-alkaloid complexes were evaluated for targeting chemotherapy in breast cancer MCF-7 cells.